Recurrent Cytogenetic Abnormalities in Acute Myeloid Leukemia

Area of Science:

• Hematology
• Cytogenetics
• Oncology

Background:

• Acute myeloid leukemia (AML) presents a broad and heterogeneous spectrum of chromosomal abnormalities compared to other myeloid neoplasms.
• While recurrent translocations like t(8;21), t(15;17), and inv(16) are common, numerous other aberrations exist in AML.
• The WHO classification highlights specific chromosomal abnormalities crucial for AML diagnosis and prognosis.

Purpose of the Study:

• To provide a concise reference for cancer cytogenetic laboratories on common and infrequent chromosomal abnormalities in AML.
• To summarize the morphologic, cytogenetic, and clinical characteristics of 22 key chromosomal abnormalities in AML.
• To integrate FAB and WHO classifications for comprehensive understanding of AML cytogenetics.

Main Methods:

• Review and discussion of 22 common structural, numerical, and infrequent translocations in AML based on the WHO classification.
• Integration of morphology data from the French-American-British (FAB) classification with current WHO guidelines.
• Brief mention of gene mutations in normal karyotype AML identified through next-generation sequencing.

Main Results:

• Detailed summary of 22 significant chromosomal abnormalities in AML, including their morphologic, cytogenetic, and clinical features.
• Emphasis on both common recurrent translocations and infrequent but important aberrations.
• Contextualization of AML chromosomal abnormalities within the broader landscape of myeloid neoplasms.

Conclusions:

• The diverse chromosomal landscape of AML requires a comprehensive understanding for accurate diagnosis and management.
• This review serves as a valuable resource for cytogenetic laboratories analyzing AML samples.
• Future research directions include integrating next-generation sequencing findings for a more complete picture of AML pathogenesis.